For the disease model, we used the GL261 glioma cell line, which was derived from a chemically-induced C57BL/6 murine astrocytoma [28] and bears mutations in the tumor suppressor p53 and the oncogene KRas [35]. The gene discussed is KRAS; the disease is central nervous system cancer.